NTRBW
Nutriband Inc. WarrantNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
$-0.51
Beta
1.93
52W High
$4.50
52W Low
$0.80
50-Day MA
$1.25
200-Day MA
$1.60
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Nutriband Inc. Warrant
Nutriband Inc. Warrant (NTRBW) offers a unique investment opportunity tied to Nutriband Inc., a forward-thinking biotech company known for its revolutionary transdermal drug delivery systems. The company focuses on improving patient outcomes in pain management and addiction treatment, characterized by an innovative therapeutic pipeline designed to address significant healthcare challenges. With its proprietary technologies and a strategic vision, Nutriband is poised to leverage growth opportunities in the dynamic pharmaceutical landscape, making it an attractive prospect for institutional investors targeting the biotech sector.
Fundamentals
| Revenue (TTM) | $2.28M |
| Gross Profit (TTM) | 763,310 |
| EBITDA | $-9.03M |
| Operating Margin | -1121.00% |
| Return on Equity | -136.10% |
| Return on Assets | -55.20% |
| Revenue/Share (TTM) | $0.20 |
| Book Value | $0.62 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -46.40% |
| Shares Outstanding | 0 |
| Float | $4.91M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
134.84%
HV 20-Day
95.23%
HV 30-Day
124.78%
HV 60-Day
100.01%
HV Rank
—
Volatility is currently expanding
Data last updated: 5/5/2026